Published in J Gen Microbiol on September 01, 1992
Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev (1998) 9.76
Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob Agents Chemother (1993) 3.79
Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother (1997) 3.78
Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J Clin Microbiol (1997) 3.54
Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J Clin Microbiol (1993) 2.87
Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother (1998) 2.03
Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance. Antimicrob Agents Chemother (1996) 1.89
Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel. J Clin Microbiol (2000) 1.49
Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin Microbiol (1999) 1.31
Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid-ferric citrate agar. J Clin Microbiol (2001) 1.26
Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode. J Clin Microbiol (2000) 1.25
Increased phenotypic switching in strains of Candida albicans associated with invasive infections. J Clin Microbiol (1994) 1.12
Differential filamentation of Candida albicans and Candida dubliniensis Is governed by nutrient regulation of UME6 expression. Eukaryot Cell (2010) 1.07
Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans. Antimicrob Agents Chemother (1999) 1.07
Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans. J Clin Microbiol (2007) 1.06
Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals. J Clin Microbiol (2002) 1.05
Molecular epidemiology of Candida isolates from AIDS patients showing different fluconazole resistance profiles. J Clin Microbiol (1995) 1.00
Molecular mechanisms of itraconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother (2003) 0.98
The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance. Antimicrob Agents Chemother (2002) 0.94
Phenotypic screening, transcriptional profiling, and comparative genomic analysis of an invasive and non-invasive strain of Candida albicans. BMC Microbiol (2008) 0.85
Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression. Antimicrob Agents Chemother (2005) 0.85
Susceptibility of Candida dubliniensis to salivary histatin 3. Antimicrob Agents Chemother (2003) 0.78
Differentially expressed proteins in derivatives of Candida albicans displaying a stable histatin 3-resistant phenotype. Antimicrob Agents Chemother (2007) 0.76
Transcriptomics Analysis of Candida albicans Treated with Huanglian Jiedu Decoction Using RNA-seq. Evid Based Complement Alternat Med (2016) 0.75
Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A (1998) 21.41
Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology (1995) 8.08
The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science (2004) 7.74
Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother (1997) 3.78
Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS (1997) 3.32
Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology (1999) 2.26
Characteristics of patients with orofacial granulomatosis. Oral Dis (2011) 2.12
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin Microbiol (1999) 2.10
Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother (1998) 2.03
Analysis of the reduction in expression of tetracycline resistance determined by transposon Tn10 in the multicopy state. Mol Gen Genet (1981) 1.97
Analysis of the genetic contamination of salt-sensitive Dahl/Rapp rats. Hypertension (1994) 1.96
Rapid identification of Candida dubliniensis with commercial yeast identification systems. J Clin Microbiol (1999) 1.96
Chemotaxis of lymphoblasts. Nature (1975) 1.92
Staphylococcus aureus bacteriophages mediating the simultaneous lysogenic conversion of beta-lysin, staphylokinase and enterotoxin A: molecular mechanism of triple conversion. J Gen Microbiol (1989) 1.83
Oral Candida in HIV infection and AIDS: new perspectives/new approaches. Crit Rev Microbiol (1993) 1.83
Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J Med Microbiol (1996) 1.81
A single amino acid substitution converts a carboxylesterase to an organophosphorus hydrolase and confers insecticide resistance on a blowfly. Proc Natl Acad Sci U S A (1997) 1.76
Candida dubliniensis: phylogeny and putative virulence factors. Microbiology (1998) 1.76
Fabrication of poly(ethylene glycol) hydrogel microstructures using photolithography. Langmuir (2001) 1.76
Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol (1996) 1.68
Enterobacter cloacae in a haematology/oncology ward--first impressions. J Hosp Infect (1989) 1.61
Evaluation of clinician attitudes to the implementation of novel haemostatic techniques. J R Army Med Corps (2005) 1.60
Emerging pathogens. Med Mycol (2000) 1.59
Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes. J Clin Microbiol (1998) 1.57
Identification of Candida dubliniensis based on temperature and utilization of xylose and alpha-methyl-D-glucoside as determined with the API 20C AUX and vitek YBC systems. J Clin Microbiol (1999) 1.54
The natural history of traumatic aneurysms of the aorta. Surgery (1967) 1.54
Analysis of tetracycline resistance encoded by transposon Tn10: deletion mapping of tetracycline-sensitive point mutations and identification of two structural genes. J Bacteriol (1983) 1.53
Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel. J Clin Microbiol (2000) 1.49
Involvement of multiple Cryptococcus neoformans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification of polymorphic DNA and DNA fingerprinting. J Clin Microbiol (1995) 1.46
Oat cell carcinoma of the lung. A review of 138 cases. Cancer (1969) 1.46
Genomic DNA fingerprinting of clinical isolates of Helicobacter pylori using short oligonucleotide probes containing repetitive sequences. J Appl Bacteriol (1996) 1.45
Persistent nicorandil induced oral ulceration. Heart (2004) 1.44
Antigen-induced locomotor responses in lymphocytes. J Exp Med (1977) 1.42
Some implications of chaos theory for the genetic analysis of human development and variation. Twin Res (1999) 1.42
Evolution of an organophosphate-degrading enzyme: a comparison of natural and directed evolution. Protein Eng (2003) 1.40
Molecular cloning and characterization of esterase-6, a serine hydrolase of Drosophila. Proc Natl Acad Sci U S A (1987) 1.40
The histoplasmin latex agglutination test: clinical evaluation and a review of the literature. Am J Med Sci (1966) 1.39
Chemotaxis of mitogen-activated human lymphocytes and the effects of membrane-active enzymes. Clin Exp Immunol (1976) 1.39
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. Clin Infect Dis (2012) 1.36
Amplification of DNA from preserved specimens shows blowflies were preadapted for the rapid evolution of insecticide resistance. Proc Natl Acad Sci U S A (2006) 1.35
Staphylococcal toxins in human disease. Soc Appl Bacteriol Symp Ser (1990) 1.33
Structural basis for oseltamivir resistance of influenza viruses. Vaccine (2009) 1.31
Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin Microbiol (1999) 1.31
Candida dubliniensis: An update. Rev Iberoam Micol (1999) 1.31
Epidemiological typing of MRSA isolates from blood cultures taken in Irish hospitals participating in the European Antimicrobial Resistance Surveillance System (1999-2003). Eur J Clin Microbiol Infect Dis (2006) 1.30
Novel organization of the site-specific integration and excision recombination functions of the Staphylococcus aureus serotype F virulence-converting phages phi 13 and phi 42. Mol Microbiol (1995) 1.29
Bacterial infection of aortic aneurysms. A clinicopathologic study. Am J Surg (1967) 1.29
The same amino acid substitution in orthologous esterases confers organophosphate resistance on the house fly and a blowfly. Insect Biochem Mol Biol (1999) 1.28
Effects of staphylococcal products on locomotion and chemotaxis of human blood neutrophils and monocytes. J Med Microbiol (1976) 1.27
A lipid chemotactic factor from anaerobic coryneform bacteria including Corynebacterium parvum with activity for macrophages and monocytes. Immunology (1976) 1.27
Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid-ferric citrate agar. J Clin Microbiol (2001) 1.26
A simple method for the study in vivo of bacterial growth and accompanying host response. J Infect (1980) 1.23
Antigenic determinants of influenza virus hemagglutinin. II. Antigenic reactivity of the isolated N-terminal cyanogen bromide peptide of A/Memphis/72 hemagglutinin heavy chain. Virology (1979) 1.23
Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans. Fungal Genet Biol (2007) 1.22
Cloning and expression of the Haemophilus influenzae transferrin receptor genes. Mol Microbiol (1996) 1.18
Outer membrane protein D15 is conserved among Haemophilus influenzae species and may represent a universal protective antigen against invasive disease. Infect Immun (1997) 1.17
Tiny TIM: a small, tetrameric, hyperthermostable triosephosphate isomerase. J Mol Biol (2001) 1.17
Molecular analysis of duplicated esterase genes in Drosophila melanogaster. Mol Biol Evol (1990) 1.14
Enterotoxin production by Staphylococcus aureus isolates from cases of septicaemia and from healthy carriers. J Med Microbiol (1989) 1.13
Molecular typing of methicillin and gentamicin resistant Staphylococcus aureus in Dublin. Eur J Clin Microbiol (1986) 1.13
Enrichment of an endosulfan-degrading mixed bacterial culture. Appl Environ Microbiol (2000) 1.12
Nonadditive effects of leaf litter species diversity on breakdown dynamics in a detritus-based stream. Ecology (2007) 1.12
The evolution of an alpha-esterase pseudogene inactivated in the Drosophila melanogaster lineage. Mol Biol Evol (2000) 1.12
The DNA-based human karyotype. Cytometry (1984) 1.11
Impact of a nationwide limited prescribing list: preliminary findings. Drug Intell Clin Pharm (1987) 1.11
Enzymatic bioremediation: from enzyme discovery to applications. Clin Exp Pharmacol Physiol (2004) 1.10
MDR1-mediated drug resistance in Candida dubliniensis. Antimicrob Agents Chemother (2001) 1.10
Alterations of mononuclear phagocyte function induced by Lewis lung carcinoma in C57BL mice. Br J Cancer (1977) 1.10
Bronchiolar carcinoma: a valid clinicopathologic entity? A study of 30 cases. Cancer (1969) 1.10
Molecular cloning and characterization of the genetic determinant encoding CS3 fimbriae of enterotoxigenic Escherichia coli. Microb Pathog (1987) 1.09
Primary mycotic aneurysms of the aorta. Report of case and review of the literature. Arch Surg (1967) 1.09
Isolation of C. dubliniensis from insulin-using diabetes mellitus patients. J Oral Pathol Med (2000) 1.09
Identification of a juvenile hormone esterase gene by matching its peptide mass fingerprint with a sequence from the Drosophila genome project. Insect Biochem Mol Biol (2001) 1.08
Acclimatization of rats after ground transportation to a new animal facility. Lab Anim (2007) 1.08
Susceptibility to antimicrobial agents and analysis of plasmids in gentamicin- and methicillin-resistant Staphylococcus aureus from Dublin hospitals. J Med Microbiol (1985) 1.08
The Haemophilus influenzae HtrA protein is a protective antigen. Infect Immun (1998) 1.08
Azole susceptibility and resistance in Candida dubliniensis. Biochem Soc Trans (2005) 1.07
Lack of a relationship between Lewis antigen expression and cagA, CagA, vacA and VacA status of Irish Helicobacter pylori isolates. FEMS Immunol Med Microbiol (1999) 1.07
Isogenic strain construction and gene targeting in Candida dubliniensis. J Bacteriol (2001) 1.06
Spectroscopic studies of the seven-iron-containing ferredoxins from Azotobacter vinelandii and Thermus thermophilus. Biochim Biophys Acta (1987) 1.05
An epidemiological study of Candida species infection in cancer patients using genetic fingerprinting and morphotyping. J Hosp Infect (1995) 1.04
Glucose monitoring using implanted fluorescent microspheres. IEEE Eng Med Biol Mag (2000) 1.04
Hydrolysis of organophosphorus insecticides by in vitro modified carboxylesterase E3 from Lucilia cuprina. Insect Biochem Mol Biol (2004) 1.03
Importation of methicillin-resistant Staphylococcus aureus from Baghdad to Dublin and subsequent nosocomial spread. J Hosp Infect (1990) 1.02
Characterisation of MRSA from Malta and the description of a Maltese epidemic MRSA strain. Eur J Clin Microbiol Infect Dis (2009) 1.02